Hanjabaado badan oo fayraska neef-mareenka ah xilliga jiilaalka
Tallaabooyinka lagu dhimayo gudbinta SARS-CoV-2 ayaa sidoo kale waxtar u yeeshay dhimista gudbinta fayrasyada kale ee neef-mareenka.Maaddaama waddamo badan ay yareeyaan isticmaalka tillaabooyinkan oo kale, SARS-CoV-2 waxay la wareegi doontaa fayrasyada kale ee neef-mareenka, kordhinta suurtagalnimada caabuqyada wadajirka ah.
Khubaradu waxa ay saadaaliyeen in uu jiri karo fayras saddex laab ah jiilaalkan taas oo ay ugu wacan tahay isku darka meelaha ugu sarreeya ee hargabka (Flu) iyo fayraska neef-mareenka (RSV) oo wata fayraska faafa ee SARS-CoV-2.Tirada xaaladaha hargabka iyo RSV sanadkan aad ayay uga badan tahay isla muddadaas sanadihii hore.Kala duwanaanshaha cusub ee BA.4 iyo BA.5 ee fayraska SARS-CoV-2 ayaa ka sii daray cudurka mar kale.
"Maalinta Hargabka Adduunka 2022 Symposium" ee Noofambar 1, 2022, Zhong Nanshan, oo ah aqoonyahan ka tirsan Akademiyada Shiinaha ee Injineerinka, ayaa si buuxda u falanqeeyay xaaladda hargabka ee gudaha iyo dibadda, wuxuuna sameeyay cilmi-baaris iyo xukunkii ugu dambeeyay ee xaaladda hadda jirta."Dunidu wali waxay wajaheysaa halista faafitaanka sare ee faafitaanka fayraska SARS-CoV-2 iyo faafitaanka hargabka."Waxa uu tilmaamay, "Gaar ahaan jiilaalkan, weli waxay u baahan tahay in la xoojiyo cilmi-baarista arrimaha sayniska ee ka hortagga iyo xakamaynta hargabka."Marka loo eego tirakoobka US CDC, tirada booqashooyinka isbitaallada ee caabuqyada neef-mareenka ee Mareykanka ayaa si aad ah u kordhay sababtoo ah isku darka hargabka iyo caabuqyada cusub ee wadnaha.
Korodhka ogaanshaha RSV iyo booqashooyinka waaxda degdega ah ee la xidhiidha RSV iyo cusbitaalada gobolo badan oo Maraykan ah, iyada oo gobolada qaar ay ku dhow yihiin heerarka ugu sarreeya xilliyeed.Waqtigan xaadirka ah, tirada kiisaska caabuqa RSV ee gudaha Mareykanka ayaa gaartay meeshii ugu sareysay muddo 25 sano ah, taasoo keentay in isbitaalada carruurta ay buux dhaafaan, iskuulada qaarna waa la xiray.
Cudurka hargabka ayaa ka dilaacay Australia bishii April ee sanadkan wuxuuna socday ku dhawaad 4 bilood.Laga soo bilaabo Sebtembar 25, waxaa jiray 224,565 xaaladood oo shaybaadhka la xaqiijiyay oo hargab ah, taasoo keentay 305 dhimasho ah.Taas bedelkeeda, marka la eego tallaabooyinka ka hortagga fayraska SARS-CoV-2, waxaa Australia ka dhici doona ilaa 21,000 xaaladood oo hargab ah sanadka 2020 iyo in ka yar 1,000 sanadka 2021.
Warbixinta toddobaadlaha ah ee 35-aad ee Xarunta Hargabka Shiinaha ee 2022 waxay muujineysaa in saamiga kiisaska hargabka ee gobollada waqooyi ay ka sarreeyaan heerka isla muddadaas 2019-2021 4 toddobaad oo isku xigta, xaaladda mustaqbalkana waxay noqon doontaa mid aad u daran.Laga soo bilaabo bartamihii bishii Juun, tirada xaaladaha hargabka u eg ee laga soo sheegay Guangzhou waxay korodhay 10.38 jeer marka la barbar dhigo sannadkii hore.
Natiijooyinka daraasad qaabayn ah oo ka kooban 11 waddan oo ay soo saartay Lancet Global Health bishii Oktoobar waxay muujisay in u nuglaanta dadka hadda jira ee hargabku ay kordheen ilaa 60% marka loo eego ka hor faafitaanka.Waxa kale oo ay saadaalisay in baaxadda ugu sarreysa ee xilliga hargabka 2022 uu kordho 1-5 jeer, iyo cabbirka cudurku uu kordho ilaa 1-4 jeer.
212,466 qaangaar ah oo qaba caabuqa SARS-CoV-2 kuwaas oo la dhigay cusbitaalka.Tijaabooyin ku saabsan caabuqyada fayraska neef-mareenka ayaa la duubay 6,965 bukaan oo qaba SARS-CoV-2.Caabuqa fayraska ayaa laga helay 583 (8 · 4%) bukaanada: 227 bukaan ayaa qabay fayraska hargabka, 220 bukaan ayaa qabay fayraska syncytial neef-mareenka, iyo 136 bukaan ayaa qabay adenoviruses.
Caabuqa fayraska hargabka ayaa lala xiriiriyay kororka fursadaha helitaanka hawo-mareenada faafa marka la barbar dhigo SARS-CoV-2 mono-infection.Caabuqa SARS-CoV-2 oo ay la socdaan fayrasyada hargabka iyo adenovirus-ka ayaa mid walba si weyn loola xiriiriyay kororka dhimashada.AMA-da hawo-mareenka farsamada ee faafitaanka hargabka wadajirka ah wuxuu ahaa 4.14 (95% CI 2.00-8.49, p=0.0001).OR dhimashada cisbitaalka ee bukaanada hargabka la wadaaga waxay ahaayeen 2.35 (95% CI 1.07-5.12, p=0.031).OR dhimashada cisbitaalka ee bukaanada qaba adenovirus waxay ahaayeen 1.6 (95% CI 1.03-2.44, p=0.033).
Natiijooyinka daraasaddan ayaa si cad noo sheegaysa in la-qaadista fayraska SARS-CoV-2 iyo fayraska hargabku ay tahay xaalad khatar gaar ah leh.
Kahor inta uusan dillaacin SARS-CoV-2, calaamadaha fayrasyada neef-mareenka ee kala duwan aad bay isugu shabahaan, laakiin hababka daawaynta way ka duwanaayeen.Haddii bukaannadu aysan ku tiirsanayn baaritaanno badan, daaweynta fayraska neef-mareenka ayaa sii adkaan doonta, waxayna si fudud u lumin doontaa agabka isbitaalka inta lagu jiro xilliyada sare ee dhacdooyinka.Sidaa darteed, baaritaanno badan oo wadajir ah ayaa door muhiim ah ka ciyaara ogaanshaha bukaan-socodka, dhakhaatiirtu waxay awoodaan inay bixiyaan kala duwanaansho ogaanshaha cudur-sidaha bukaan-socodka ee bukaannada leh calaamadaha neef-mareenka iyada oo loo marayo muunad suuf ah.
Makro & Tijaabada-yar ee SARS-CoV-2 Neefsashada ee Isku-dhafka Isku-dhafka ah
Macro & Micro-Test waxay leedahay aalado farsamo sida PCR tireed fluorescent, amplification isothermal, talaalka, iyo POCT molecular, waxayna bixisaa noocyo kala duwan oo ah SARS-CoV-2 alaabada ogaanshaha wadajirka neefsashada.Dhammaan alaabtu waxay heleen shahaadada EU CE, oo leh wax qabad wax soo saar aad u wanaagsan iyo khibrad isticmaale oo togan.
1. Xidhmada RT-PCR fluorescent ee wakhtiga dhabta ah ee lagu ogaanayo lix nooc oo cudur-sidaha neef-mareenka ah
Xakamaynta Gudaha: Si buuxda ula soco habka tijaabada si aad u hubiso tayada tijaabooyinka.
Waxtarka sare: Multiplex-waqtiga dhabta ah PCR waxay ogaataa bartilmaameedyo kala duwan oo u gaar ah SARS-CoV-2, Flu A, Flu B, Adenovirus, Mycoplasma pneumoniae, iyo fayraska syncytial ee neefsashada.
Dareen sare: 300 koobi/ml ee SARS-CoV-2, 500 koobi/ml ee fayraska hargabka A, 500 koobi/ml ee fayraska hargabka B, 500 koobi/ml oo ah fayraska syncytial ee neefsashada, 500 koobi/ml ee mycoplasma pneumoniae, iyo 500 koobi
2. SARS-CoV-2/ Hargabka A / Hargabka B Nucleic Acid Isku-dhafan Xidhmada Garashada (Fluorescence PCR)
Xakamaynta Gudaha: Si buuxda ula soco habka tijaabada si aad u hubiso tayada tijaabooyinka.
Waxtarka sare: Multiplex-waqtiga dhabta ah PCR waxay ogaataa bartilmaameedyo kala duwan oo u gaar ah SARS-CoV-2, Flu A iyo Flu B.
Dareen sare: 300 koobi/ml ee SARS-CoV-2,500Koobi/ml ee lFV A iyo 500Koobi/ml ee lFV B.
3. SARS-CoV-2, Hargabka A iyo Hargabka B Antigen Detection Kit (Immunochromatography)
fududahay in la isticmaalo
Gaadiidka Heerkulka qolka & kaydinta 4-30°℃
Dareen sare & gaar ahaan
| Magaca Alaabta | Tilmaamid |
| Qalabka RT-PCR fluorescent ee waqtiga dhabta ah ee lagu ogaanayo lix nooc oo cudur-sidaha neef-mareenka ah | 20 tijaabo/xirmo,48 tijaabo/xirmo,50 tijaabo/xirmo |
| SARS-CoV-2 / Hargabka A / Hargabka B Nucleic Acid Isku-dhafka Lagu Garto (Fluorescence PCR) | 48 tijaabo/xirmo,50 tijaabo/xirmo |
| SARS-CoV-2, Hargabka A iyo Hargabka B Qalabka lagu ogaado Antigen-ka (Immunochromatography) | 1 shaybaar / qalab,20 tijaabo/xirmo |
Waqtiga post: Dec-09-2022